• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:林慧,葛茂旭.基于网络药理学探讨调神攻坚汤治疗肝纤维化的作用机制[J].药学研究,2022,41(7):435-441[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2539次   下载 2881次 本文二维码信息
码上扫一扫!
基于网络药理学探讨调神攻坚汤治疗肝纤维化的作用机制
林慧,葛茂旭
字体:加大+|默认|缩小-
(山东大学齐鲁医院,山东 济南 250012)
摘要:
目的 基于网络药理学研究方法探讨调神攻坚汤治疗肝纤维化的作用机制。方法 检索 TCMSP 和BATMAN-TCM数据库得到调神攻坚汤的有效活性成分及其相关作用靶点;并与检索OMIM和Genecards数据库得到的肝纤维化疾病作用靶点利用R语言筛选共同靶点;通过STRING数据库构建靶点间的蛋白互作PPI网络,随后利用Metascape平台进行GO功能和KEGG通路富集分析;利用 Cytoscape 3.7.2软件构建“中药-活性成分-疾病”靶点网络图,并经Cytohubba插件的MCC算法筛选出核心蛋白;再将其导入Genecards数据库中获得亚细胞分布。结果 通过筛选共计获得调神攻坚汤有效活性成分166个,作用靶点596个;经匹配后此方剂治疗肝纤维化的潜在靶点为193个;其中核心包括FN1、MMP2、TNF、IL-6、STAT3、CTNNB1等;GO以及KEGG分析显示调神攻坚汤可能通过调控炎症反应、脂质代谢、细胞凋亡等生物学过程治疗肝纤维化,并且涉及HIF-1、Foxo、PPAR等细胞信号转导通路。结论 通过网络药理学方法初步验证调神攻坚汤治疗肝纤维化是一个“多组分-多靶点-多通路”的过程,并预测其潜在作用机制,为后续临床及基础研究提供理论依据。
关键词:  网络药理学  调神攻坚汤  肝纤维化  作用机制  信号通路
DOI:10.13506/j.cnki.jpr.2022.07.003
基金项目:山东省自然科学基金青年基金项目(No.ZR2021QH204)
Study on the Mechanism of Tiaoshen Gongjian Decoction Intervening Liver Fibrosis Based on Network Pharmacology
LIN Hui,GE Maoxu
(Qilu Hospital of Shandong University,Jinan 250012,China)
Abstract:
Objective Study on the mechanism of Tiaoshen Gongjian Decoction intervening liver fibrosis based on network pharmacology.Methods The active ingredients and targets of Tiaoshen Gongjian Decoction were searched through TCMSP and BATMAN-TCM database; which were intersected with the therapeutic targets of liver fibrosis obtained from OMIM and Genecards database; protein-protein interaction (PPI) network of the above intersected genes was constructed through STRING database, GO ontology and KEGG pathway analyses were carried out by Metascape platform; Cytoscape 3.7.2 software was applied to construct a visual regulatory network map of " Chinese medicinal formulae - active components - disease", and the core proteins were screened out by MCC algorithm of Cytohubba and subsequently imported into Genecards database to acquire their subcellular distributions.Results A total of 166 active ingredients and 596 targets of Tiaoshen Jiejian decoction were obtained. After matching to the therapeutic targets of liver fibrosis, 193 potential targets were identified. The core proteins mainly include FN1, MMP2, TNF, IL-6, STAT3, CTNNB1, etc. GO and KEGG analysis showed that the therapeutic effects of this decoction in treating liver fibrosis might concentrate on regulating inflammatory response, lipid metabolism, apoptosis and other biological processes, and involve in HIF-1, FOXO, PPAR and other signaling pathways.Conclusion It was preliminarily verified that Tiaoshen Xiaojian decoction is a "multi-component, multi-target and multi-pathway" process in the treatment of liver fibrosis through network pharmacology, which potential mechanisms was predicted, providing theoretical basis for subsequent clinical and basic research.
Key words:  Network pharmacology  Tiaoshen Gongjian Decoction  Liver fibrosis  Mechanism of action  Signaling pathway
今日访问量:2433    总访问量:55338849
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司